World Congress of Pharmacy and Pharmacal Sciences 64th Congress of the FIP 4-9 September at the Hyatt Regency in New Orleans Special Interest Group on Nuclear / Radiologic Pharmacy Monday, 6 September 2004 10:30 - 12:00 Special Interest Group Meeting (open meeting) 14:00 - 17:00 Symposium: Diagnostics: A Patient and Pharmacist Partnership in Healthcare, Chair: Clyde Cole, USA Role of diagnostics in staging cancer and monitoring therapeutic outcomes using PET and CT Laurie Ponto, USA Radiopharmaceuticals in Oncology James Ponto, USA Update on radionuclide therapy in the treatment of cancer: Alpha emitters in radionuclide therapy; new insights Mike Zalutsky, USA Wednesday, 8 September 2004 9:00 - 12:00 Symposium: Osteoporosis and Fractures: Diagnosis, Therapies and Pharmacoepidemiology (Joint Symposium with SIG Pharmacoeconmics / Pharmacoepidemiology) Chairs: Bert Leufkens, The Netherlands and Stanley Shaw, USA Imaging and Advances in Diagnosis Osteoporosis Mary Bouxsein, USA New Preventative and Treatment Strategies in Management Janet Hock, USA Role of Biphosphonates in Osteoporosis Cliff Rosen, USA Contribution of Bone Imaging in the Pharmacoepidemiology of Fractures Tjeerd van Staa, The Netherlands Registration information www.fip.org/neworleans . One day registration available.